Fauci AS, Morens DM. The perpetual challenge of infectious diseases. N Engl J Med. 2012;366:454–61.
CAS
PubMed
Google Scholar
Albright FS, Orlando P, Pavia AT, Jackson GG, Albright LAC. Evidence for a heritable predisposition to death due to influenza. J Infect Dis. 2008;197:18–24.
PubMed
Google Scholar
Sørensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318:727–32.
PubMed
Google Scholar
Cooke GS, Hill AVS. Genetics of susceptibility to human infectious disease. Nat Rev Genet. 2001;2:967–77.
CAS
PubMed
Google Scholar
Chapman SJ, Hill AVS. Human genetic susceptibility to infectious disease. Nat Rev Genet. 2012;13:175–88.
CAS
PubMed
Google Scholar
de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523–34.
PubMed
PubMed Central
Google Scholar
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.
CAS
PubMed
PubMed Central
Google Scholar
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–3.
CAS
PubMed
PubMed Central
Google Scholar
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.
CAS
PubMed
PubMed Central
Google Scholar
Lauc G, Sinclair D. Biomarkers of biological age as predictors of COVID-19 disease severity. Aging. 2020;12:6490–1.
PubMed
PubMed Central
Google Scholar
Wu JT, Leung K, Bushman M, Kishore N, Niehus R, de Salazar PM, Cowling BJ, Lipsitch M, Leung GM. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020;26:506–10.
CAS
PubMed
PubMed Central
Google Scholar
Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8:e21.
CAS
PubMed
PubMed Central
Google Scholar
Xu X, Sun J, Nie S, Li H, Kong Y, Liang M, Hou J, Huang X, Li D, Ma T, Peng J, Gao S, Shao Y, Zhu H, Lau JY, Wang G, Xie C, Jiang L, Huang A, Yang Z, Zhang K, Hou FF. Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China. Nat Med. 2020;26:1193–5.
CAS
PubMed
Google Scholar
Patarčić I, Gelemanović A, Kirin M, Kolčić I, Theodoratou E, Baillie KJ, de Jong MD, Rudan I, Campbell H, Polašek O. The role of host genetic factors in respiratory tract infectious diseases: systematic review, meta-analyses and field synopsis. Sci Rep. 2015;5:16119.
PubMed
PubMed Central
Google Scholar
Casanova JL, Su HC, Effort CHG. A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection. Cell. 2020;181:1194–99.
Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215–20.
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:1–10.
Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect / Wei Mian Yu Gan Ran za Zhi. 2020;53:425–35.
Asselta R, Paraboschi EM, Mantovani A, Duga S. ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy. Aging. 2020;12:10087–98.
Cao Y, Li L, Feng Z, Wan S, Huang P, Sun X, Wen F, Huang X, Ning G, Wang W. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11.
CAS
PubMed
PubMed Central
Google Scholar
Gill D, Arvanitis M, Carter P, Hernandez Cordero AI, Jo B, Karhunen V, Larsson SC, Li X, Lockhart SM, Mason AM, Pashos E, Saha A, Tan V, Zuber V, Bosse Y, Fahle S, Hao K, Jiang T, Joubert P, Lunt AC, Wh O, Roberts DJ, Timens W, van den Berge M, Watkins NA, Battle A, Butterworth AS, Danesh J, Engelhard BE, Peters JE, Sin D, Burgess S. ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study. medRxiv. 2020:2020.2004.2010.20059121..
Mehrian-Shai R, Novelli G, Vasiliou V, Watt J, Reichardt JKV. Genomics of COVID-19: molecular mechanisms going from susceptibility to severity of the disease. Hum Genomics. 2020;14:22.
CAS
PubMed
PubMed Central
Google Scholar
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA, Group P-P. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
PubMed
PubMed Central
Google Scholar
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. PLoS Med. 2009;6:e1000100.
PubMed
PubMed Central
Google Scholar
Plüddemann A, Aronson JK, Onakpoya I, Heneghan C, Mahtani KR. Redefining rapid reviews: a flexible framework for restricted systematic reviews. BMJ Evid Based Med. 2018;23:201–3.
PubMed
Google Scholar
Schünemann HJ, Moja L. Reviews: Rapid! Rapid! Rapid! …and systematic. Syst Rev. 2015;4:4.
PubMed
PubMed Central
Google Scholar
Rathbone J, Albarqouni L, Bakhit M, Beller E, Byambasuren O, Hoffmann T, Scott AM, Glasziou P. Expediting citation screening using PICo-based title-only screening for identifying studies in scoping searches and rapid reviews. Syst Rev. 2017;6:233.
PubMed
PubMed Central
Google Scholar
Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, Chen PJ, Su YW, Lim KH, Tsai ZU, Lin RY, Lin RS, Huang CH. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:1–7.
Chiu RWK, Tang NLS, Hui DSC, Chung GTY, Chim SSC, Chan KCA, Sung YM, Chan LYS, Tong YK, Lee WS, Chan PKS, Lo YMD. ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem. 2004;50:1683–6.
CAS
PubMed
PubMed Central
Google Scholar
Itoyama S, Keicho N, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Ohashi J, Hijikata M, Matsushita I, Kawana A, Yanai H, Kirikae T, Kuratsuji T, Sasazuki T. ACE1 polymorphism and progression of SARS. Biochem Biophys Res Commun. 2004;323:1124–9.
CAS
PubMed
PubMed Central
Google Scholar
Ng MHL, Lau KM, Li L, Cheng SH, Chan WY, Hui PK, Zee B, Leung CB, Sung JJY. Association of human-leukocyte-antigen class I (B*0703) and class II (DRB1*0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis. 2004;190:515–8.
CAS
PubMed
Google Scholar
Chan KC, Tang NL, Hui DS, Chung GT, Wu AK, Chim SS, Chiu RW, Lee N, Choi KW, Sung YM, Chan PK, Tong YK, Lai ST, Yu WC, Tsang O, Lo YM. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis. 2005;5:26.
PubMed
PubMed Central
Google Scholar
Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha LD, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. Biochem Biophys Res Commun. 2005;329:1234–9.
CAS
PubMed
PubMed Central
Google Scholar
Ip WK, Chan KH, Law HK, Tso GH, Kong EK, Wong WH, To YF, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Jensenius JC, Turner MW, Peiris JS, Lau YL. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;191:1697–704.
CAS
PubMed
Google Scholar
Itoyama S, Keicho N, Hijikata M, Quy T, Phi NC, Long HT, Ha LD, Van Ban V, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T. Identification of an alternative 5′-untranslated exon and new polymorphisms of angiotensin-converting enzyme 2 gene: Lack of association with SARS in the Vietnamese population. Am J Med Genet. 2005;136(A):52–7.
PubMed
Google Scholar
Yuan FF, Tanner J, Chan PKS, Biffin S, Dyer WB, Geczy AF, Tang JW, Hui DSC, Sung JJY, Sullivan JS. Influence of FcγRIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens. 2005;66:291–6.
CAS
PubMed
PubMed Central
Google Scholar
Zhang H, Zhou G, Zhi L, Yang H, Zhai Y, Dong X, Zhang X, Gao X, Zhu Y, He F. Association between mannose-binding lectin gene polymorphisms and susceptibility to severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005;192:1355–61.
CAS
PubMed
Google Scholar
Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. Nat Genet. 2006;38:38–46.
CAS
PubMed
Google Scholar
Chong WP, Ip WKE, Tso GHW, Ng MW, Wong WHS, Law HKW, Yung RWH, Chow EY, Au KL, Chan EYT, Lim W, Peiris JSM, Lau YL. The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis. 2006;6:1–4.
He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, Plancoulaine S, Tang F, Zhan L, Yang H, Wang T, Richardus JH, Habbema JD, Cao W. Association of SARS susceptibility with single nucleic acid polymorphisms of OAS1 and MxA genes: a case-control study. BMC Infect Dis. 2006;6:106.
PubMed
PubMed Central
Google Scholar
Chen WJ, Yang JY, Lin JH, Fann CSJ, Osyetrov V, King CC, Chen YMA, Chang HL, Kuo HW, Liao F, Ho MS. Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin Infect Dis. 2006;42:1561–9.
PubMed
Google Scholar
Chen YM, Liang SY, Shih YP, Chen CY, Lee YM, Chang L, Jung SY, Ho MS, Liang KY, Chen HY, Chan YJ, Chu DC. Epidemiological and genetic correlates of severe acute respiratory syndrome coronavirus infection in the hospital with the highest nosocomial infection rate in Taiwan in 2003. J Clin Microbiol. 2006;44:359–65.
PubMed
PubMed Central
Google Scholar
Chan KYK, Ching JCY, Xu MS, Cheung ANY, Yip SP, Yam LYC, Lai ST, Chu CM, Wong ATY, Song YQ, Huang FP, Liu W, Chung PH, Leung GM, Chow EYD, Chan EYT, Chan JCK, Ngan HYS, Tam P, Chan LC, Sham P, Chan VSF, Peiris M, Lin SCL, Khoo US. Association of ICAM3 genetic variant with severe acute respiratory syndrome. J Infect Dis. 2007;196:271–80.
CAS
PubMed
Google Scholar
Ng MW, Zhou G, Chong WP, Lee LWY, Law HKW, Zhang H, Wong WHS, Fok SFS, Zhai Y, Yung RWH, Chow EY, Au KL, Chan EYT, Lim W, Peiris JSM, He F, Lau YL. The association of RANTES polymorphism with severe acute respiratory syndrome in Hong Kong and Beijing Chinese. BMC Infect Dis. 2007;7:1–8.
Yuan FF, Boehm I, Chan PKS, Marks K, Tang JW, Hui DSC, Sung JJY, Dyer WB, Geczy AF, Sullivan JS. High prevalence of the CD14-159CC genotype in patients infected with severe acute respiratory syndrome-associated coronavirus. Clin Vaccine Immunol. 2007;14:1644–5.
CAS
PubMed
PubMed Central
Google Scholar
Li H, Tang NLS, Chan PKS, Wang CY, Hui DSC, Luk C, Kwok R, Huang W, Sung JJY, Kong QP, Zhang YP. Polymorphisms in the C-type lectin genes cluster in chromosome 19 and predisposition to severe acute respiratory syndrome coronavirus (SARS-CoV) infection. J Med Genet. 2008;45:752–8.
CAS
PubMed
Google Scholar
Wang S, Wei M, Han Y, Zhang K, He L, Yang Z, Su B, Zhang Z, Hu Y, Hui W. Roles of TNF-alpha gene polymorphisms in the occurrence and progress of SARS-Cov infection: a case-control study. BMC Infect Dis. 2008;8:27.
CAS
PubMed
PubMed Central
Google Scholar
Xiong P, Zeng X, Song MS, Jia SW, Zhong MH, Xiao LL, Lan W, Cai C, Wu XW, Gong FL, Wang W. Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: A cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. Int J Immunogenet. 2008;35:69–74.
CAS
PubMed
PubMed Central
Google Scholar
Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Ha LD, Van Ban V, Hoa BK, Hang NTL, Hijikata M, Sakurada S, Satake M, Tokunaga K, Sasazuki T, Quy T. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol. 2009;70:527–31.
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, Yan J, Shi Y, Li P, Liu C, Ma Q, Yang R, Wang X, Zhu L, Yang X, Cao C. Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection. BMC Infect Dis. 2009;9:1–10.
Chan KYK, Xu MS, Ching JCY, So TMK, Lai ST, Chu CM, Yam LYC, Wong ATY, Chung PH, Chan VSF, Lin CLS, Sham PC, Leung GM, Peiris JSM, Khoo US. CD209 (DC-SIGN) -336A > G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese. Hum Immunol. 2010;71:702–7.
CAS
PubMed
PubMed Central
Google Scholar
Ching JCY, Chan KYK, Lee EHL, Xu MS, Ting CKP, So TMK, Sham PC, Leung GM, Peiris JSM, Khoo US. Significance of the Myxovirus resistance A (MxA) gene—123C>A single-nucleotide polymorphism in suppressed interferon ß induction of severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2010;201:1899–908.
CAS
PubMed
Google Scholar
Ng MH, Cheng SH, Lau KM, Leung GM, Khoo US, Zee BC, Sung JJ. Immunogenetics in SARS: a case-control study. Hong Kong Med J = Xianggang Yi Xue Za Zhi. 2010;16:29–33.
CAS
PubMed
Google Scholar
Wang SF, Chen KH, Chen M, Li WY, Chen YJ, Tsao CH, Yen MY, Huang JC, Chen YMA. Human-leukocyte antigen class i Cw 1502 and Class II DR 0301 genotypes are associated with resistance to severe acute respiratory syndrome (SARS) infection. Viral Immunol. 2011;24:421–6.
CAS
PubMed
Google Scholar
Yuan FF, Velickovic Z, Ashton LJ, Dyer WB, Geczy AF, Dunckley H, Lynch GW, Sullivan JS. Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus. Virol Sin. 2014;29:128–30.
PubMed
PubMed Central
Google Scholar
Hajeer AH, Balkhy H, Johani S, Yousef MZ, Arabi Y. Association of human leukocyte antigen class II alleles with severe Middle East respiratory syndrome-coronavirus infection. Ann Thor Med. 2016;11:211–3.
CAS
Google Scholar
Kuo CL, Pilling LC, Atkins JL, Masoli JAH, Delgado J, Kuchel GA, Melzer D. APOE e4 genotype predicts severe COVID-19 in the UK Biobank community cohort. J Gerontol A Biol Sci Med Sci. 2020;XX:1–2.
Wang W, Zhang W, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19). Hla. 2020;96:194–96.
Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, Liang L, Zhang C, Dai Y, Feng Y, Sun J, Hu Z, Xiang H, Knight JC, Dong T, Jin R. Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019. J Infect Dis. 2020;222:34–7.
PubMed
PubMed Central
Google Scholar
Buschman E, Skamene E. Genetic resistance to coronavirus infection. A review. Adv Exp Med Biol. 1995;380:1–11.
CAS
PubMed
Google Scholar
Ezekowitz RA. Role of the Mannose-Binding Lectin in Innate Immunity. J Infect Dis. 2003;187:S335–9.
CAS
PubMed
Google Scholar
Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol. 2003;40:423–9.
CAS
PubMed
Google Scholar
Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37:1496–505.
CAS
PubMed
Google Scholar
Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, Ye L, Xu S, Sun R, Wang Y, Lou J. Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun. 2004;72:4410–5.
CAS
PubMed
PubMed Central
Google Scholar
Vandenbroeck K. Cytokine Gene Polymorphisms and human autoimmune disease in the era of genome-wide association studies. J Interf Cytokine Res. 2012;32:139–51.
CAS
Google Scholar
Samuel CE. Antiviral Actions of Interferons. Clin Microbiol Rev. 2001;14:778–809.
CAS
PubMed
PubMed Central
Google Scholar
Hijikata M, Mishiro S, Miyamoto C, Furuichi Y, Hashimoto M, Ohta Y. Genetic Polymorphism of the MxA Gene Promoter and Interferon Responsiveness of Hepatitis C Patients: Revisited by Analyzing Two SNP Sites (–123 and –88) in vivo and in vitro. Intervirology. 2001;44:379–82.
CAS
PubMed
Google Scholar
Law HKW, Cheung CY, Ng HY, Sia SF, Chan YO, Luk W, Nicholls JM, Peiris JSM, Lau YL. Chemokine up-regulation in SARS-coronavirus–infected, monocyte-derived human dendritic cells. Blood. 2005;106:2366–74.
CAS
PubMed
Google Scholar
Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562–9.
CAS
PubMed
Google Scholar
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020;94:e00127–20.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7:11.
CAS
PubMed
PubMed Central
Google Scholar
Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, Zhong W, Hao P. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63:457.
CAS
PubMed
PubMed Central
Google Scholar
Delanghe JR, Speeckaert MM, De Buyzere ML. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19. Clin Chem Lab Med. 2020;58:1129–30.
Saadat M. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection. Clin Chem Lab Med. 2020;58:1127–28.
Choi P, Reiser H. IL-4: role in disease and regulation of production. Clin Exp Immunol. 1998;113:317–9.
CAS
PubMed
PubMed Central
Google Scholar
Grifoni E, Valoriani A, Cei F, Lamanna R, Gelli AMG, Ciambotti B, Vannucchi V, Moroni F, Pelagatti L, Tarquini R, Landini G, Vanni S, Masotti L. Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020;81:452–82.
Herold T, Jurinovic V, Arnreich C, Lipworth BJ, Hellmuth JC, Bergwelt-Baildon MV, Klein M, Weinberger T. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146:128–36.
Zeng F, Huang Y, Guo Y, Yin M, Chen X, Xiao L, Deng G. Association of inflammatory markers with the severity of COVID-19: A meta-analysis. Int J Infect Dis. 2020;96:467–74.
CAS
PubMed
PubMed Central
Google Scholar
Tian W, Jiang W, Yao J, Nicholson CJ, Li RH, Sigurslid HH, Wooster L, Rotter JI, Guo X, Malhotra R. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020;92:1875–83.
Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: a systematic review and meta-analysis. medRxiv 2020:2020.2003.2030.20048058.
Kirtipal N, Bharadwaj S. Interleukin 6 polymorphisms as an indicator of COVID-19 severity in humans. J Biomol Struct Dyn. 2020:1–3. https://doi.org/10.1080/07391102.2020.1776640.
Khiali S, Khani E, Entezari-Maleki T. A Comprehensive review on tocilizumab in COVID-19 acute respiratory distress syndrome. J Clin Pharmacol. 2020;60:1131–46.
Maldonado-Montoro M, Cañadas-Garre M, González-Utrilla A, Ángel Calleja-Hernández M. Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis. Pharmacogenomics J. 2018;18:167–72.
CAS
PubMed
Google Scholar
Perricone C, Conigliaro P, Ciccacci C, Marcucci E, Cafaro G, Bartoloni E, Perricone R, Novelli G, Borgiani P, Gerli R. The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart. Clin Exp Rheumatol. 2020;38:580.
PubMed
Google Scholar
Snyder EM, Johnson BD. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations. Pharmacogenomics. 2020;21:695–703.
Wang L-Y, Cui J-J, OuYang Q-Y, Zhan Y, Wang Y-M, Xu X-Y, Guo C-X, Yin J. Genetic profiles in pharmacogenes indicate personalized drug therapy for COVID-19. medRxiv. 2020:2020.2003.2023.20041350.
Sanchez-Mazas A. HLA studies in the context of coronavirus outbreaks. Swiss Med Wkly. 2020;150:w20248.
PubMed
Google Scholar
Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL, Mayeux R, Farrer LA, Pericak-Vance MA, Schellenberg GD, Kauwe JSK. Assessment of the genetic variance of late-onset Alzheimer's disease. Neurobiol Aging. 2016;41:200.e213–20.
Google Scholar
Lakeman IMM, Rodríguez-Girondo M, Lee A, Ruiter R, Stricker BH, Wijnant SRA, Kavousi M, Antoniou AC, Schmidt MK, Uitterlinden AG, van Rooij J, Devilee P. Validation of the BOADICEA model and a 313-variant polygenic risk score for breast cancer risk prediction in a Dutch prospective cohort. Genet Med. 2020; https://doi.org/10.1038/s41436-41020-40884-41434.
Pal Choudhury P, Wilcox AN, Brook MN, Zhang Y, Ahearn T, Orr N, Coulson P, Schoemaker MJ, Jones ME, Gail MH, Swerdlow AJ, Chatterjee N, Garcia-Closas M. Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification. J Natl Cancer Inst. 2020;112:278–85.
PubMed
Google Scholar
Atkins JL, Masoli JA, Delgado J, Pilling LC, Kuo C-LC, Kuchel G, Melzer D. Preexisting comorbidities predicting severe COVID-19 in older adults in the UK biobank community cohort. medRxiv. 2020:2020.2005.2006.20092700.
Bero LA. Producing Independent, systematic review evidence: Cochrane's response to COVID-19. Am J Public Health. 2020;110:952–3.
PubMed
PubMed Central
Google Scholar
Godri Pollitt KJ, Peccia J, Ko AI, Kaminski N, Dela Cruz CS, Nebert DW, Reichardt JKV, Thompson DC, Vasiliou V. COVID-19 vulnerability: the potential impact of genetic susceptibility and airborne transmission. Hum Genomics. 2020;14:17.
CAS
PubMed
PubMed Central
Google Scholar
Pareek M, Bangash MN, Pareek N, Pan D, Sze S, Minhas JS, Hanif W, Khunti K. Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020;395:1421–2.
CAS
PubMed
PubMed Central
Google Scholar
Kakkar DN, Dunphy DJ, Raza DM. Ethnicity profiles of COVID-19 admissions and outcomes. J Infect. 2020;81:e110–e111.